Performance evaluation of the NeuMoDx™ EBV Quant Assay 2.0 in Comparison with cobas® EBV for epstein-barr virus DNA quantification in immunocompromised patients, a multicenter study

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 95a8c2cb49ecf93d-LAX IP: 47.97.18.252 UTC time: 2025-07-05T18:00:15+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4